Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study-Reference-Cited by-同舟云学术

Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study

Published:2007-11 Issue:10 Volume:21 Page:1381-1385
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venerol

Author:

Bhatnagar A,Kanwar AJ,Parsad D,De D

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-3083.2007.02283.x/fullpdf

Reference13 articles.

1. Association of the Köbner Phenomenon With Disease Activity and Therapeutic Responsiveness in Vitiligo Vulgaris

2. The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD

3. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spectrally-Selective and High-Resolution Visualization Detection of UVR Based on Efficient Photo-Oxidation;Microchemical Journal;2024-09

2. Phototherapy for vitiligo: A narrative review on the clinical and molecular aspects, and recent literature;Photodermatology, Photoimmunology & Photomedicine;2024-04-17

3. Whole‐body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split‐body randomized controlled trial;Photodermatology, Photoimmunology & Photomedicine;2024-03

4. Altered levels of lymphocyte enhancer-binding factor-1 modulates the pigmentation in acral and non-acral lesions of non-segmental vitiligo patients: a follow-up-based study in North India;Archives of Dermatological Research;2023-03-06

5. Vitiligo Treatments: Review of Current Therapeutic Modalities and JAK Inhibitors;American Journal of Clinical Dermatology;2023-01-30